Top Picks

We discover the best U.S. stocks through analysis of a company's performance, finances, fair stock price, and stock price trends. We provide trading strategies that include investment points, recommended/target/sell prices.

04/03 EST
Return 4.11%

T

  • "AI Chip Demand Surging"... 4Q Net Income Up 57%
Return -10.99%

F

  • Surpasses 24% Cumulative Increase... Target Price Raised
Return 18.27%

T

  • Stock Plunges After Earnings Release... "Hold" Rating Maintained
Return -53.66%

P

  • From Image Search to Shopping! AI, Ads, and Shopping Integration Driving Revenue Growth
Return -14.73%

H

  • Q4 Revenue $700 Million... +21% YoY
Return -10.49%

M

  • Surpasses $1B ARR with AI Innovation and Enterprise Expansion
Return -15.08%

S

  • Q4 Revenue Up 26%... Stock Drops After Hours
Return -10.89%

F

  • 13.62% surge after 4Q performance announcement!
Return 18.27%

C

  • Q4 Growth Continues… Revenue Up 25%
Return 98.66%

D

  • Q4 TPV Up 51%… Expected to Grow 35–45% in 2025
Return -10.00%

A

  • "Sell" Amid Continued Tech Weakness… Securing 60% Profit
Return 60.48%

I

  • Concerns Over Trend Reversal… Securing 12% Profit After Sell
Return 12.05%

D

  • Stock Declines Despite Beating Q4 Estimates
Return -10.24%

S

  • Q4 GMV Grows 26%... Armed with AI and Fintech
Return -14.96%

A

  • Record Revenue Amid Rising AI Demand... Q4 Revenue Expected to Exceed $1 Billion
Return -15.09%

A

  • Concerns Over Trend Reversal…"Sell"
Return 50.33%

C

  • Achieved a surplus in the Q4 as well...... Revenue Up 46%
Return -15.29%

V

  • Drop After Preliminary 4Q Results Announcement
Return -10.02%

I

  • Strong Demand for Omnipod Continues in Q4
Return 12.05%

B

  • Stock Declines After Earnings Release… "Sell"​​​​​​​
Return 5.99%

C

  • Achieves Record-High Backlog of $6.8B
Return -10.10%

S

  • Upward Momentum Weakens… "Sell"
Return 22.92%

C

  • Surges for 8 Consecutive Days, Cumulative Return Exceeds 140%! Target Price Raised
Return 98.66%

C

  • ARR Surpasses $1 Billion! Q4 Revenue +41%
Return 8.71%

W

  • Global Leader in Pharmaceutical Packaging... Anticipated Recovery in 2025 Driving Performance Growth
Return -10.67%

M

  • Upward Momentum Weakens… "Sell"
Return -5.75%

C

  • Uptrend Continues Ahead of Earnings... Target Price Revised Upward
Return 8.71%

S

  • High Revenue Growth Expected... Target Price Revised Upward
Return -10.89%

N

  • Surpasses 41% Cumulative Return... Second Target Price Revision
Return 29.04%